Zoetis Inc. Long-term Line of Credit
Zoetis Inc. (ZTS) had Long-term Line of Credit of $4.00 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2021-08-05
- 2021-06-30: Long-term Line of Credit $4.00M.
- 2021-03-31: Long-term Line of Credit $4.00M.
- 2020-12-31: Long-term Line of Credit $4.00M.
- 2020-09-30: Long-term Line of Credit $0.00.
| Period end | Long-term Line of Credit |
|---|---|
| 2021-06-30 | $4.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.00M 10-Q · filed 2021-08-05 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-05 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-01 |
| 2017-10-01 | $0.00 10-Q · filed 2017-11-02 |
| 2017-07-02 | $0.00 10-Q · filed 2017-08-08 |
| 2017-04-02 | $0.00 10-Q · filed 2017-05-04 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-02 |
| 2016-10-02 | $0.00 10-Q · filed 2016-11-03 |
| 2016-07-03 | $0.00 10-Q · filed 2016-08-05 |
| 2016-04-03 | $0.00 10-Q · filed 2016-05-06 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-03 |
| 2015-09-27 | $0.00 10-Q · filed 2015-11-05 |
| 2015-06-28 | $0.00 10-Q · filed 2015-08-06 |
| 2015-03-29 | $0.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-24 |
| 2014-09-28 | $0.00 10-Q · filed 2014-11-10 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |